BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2014 3:50:00 PM | Browse: 1242 | Download: 808
Publication Name World Journal of Hepatology
Manuscript ID 2230
Country Singapore
Received
2013-02-07 20:52
Peer-Review Started
2013-02-10 21:05
To Make the First Decision
2013-03-04 10:40
Return for Revision
2013-03-04 11:47
Revised
Second Decision
2013-05-07 17:39
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-05-08 09:14
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-05-17 16:38
Publish the Manuscript Online
2013-05-27 12:24
ISSN 1948-5182 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Autobiography
Article Title Prevalence and risk factors of methotrexate hepatoxicity in Asian patients with psoriasis
Manuscript Source Invited Manuscript
All Author List Chong Meng Yeo, Vui Heng Chong, Arul Earnest and Wei Lyn Yang
Funding Agency and Grant Number
Corresponding Author Dr. Chong Meng Yeo, Department of Gastroenterology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore. chong_meng_yeo@ttsh.com.sg
Key Words Hepatotoxicity; Liver fibrosis; Methotrexate; Risk factors; Cirrhosis
Core Tip Old studies have shown that the prevalence of methotrexate (MTX) associated liver fibrosis and cirrhosis to be as high as 50% and 26% respectively. Later studies have shown that the risk is much lower than previously reported. These studies have been based on western patients. To date, there is no study that had assessed MTX hepatotoxicity in Asian patient based on liver histology. This study showed that the risk of methotrexate hepatoxicity in Asian patients with psoriasis is also low and progression is minimal. We showed that ethnicity and presence of diabetes and hyperlipidemia, part of the metabolic syndrome may be important factors.
Publish Date 2013-05-27 12:24
Citation Yeo CM, Chong VH, Earnest A, Yang WL. Prevalence and risk factors of methotrexate hepatoxicity in Asian patients with psoriasis. World J Hepatol 2013; 5(5): 275-280
URL http://www.wjgnet.com/1948-5182/full/v5/i5/275.htm
DOI http://dx.doi.org/10.4254/wjh.v5.i5.275
Full Article (PDF) WJH-5-275.pdf
Manuscript File 2230-Review.doc
Answering Reviewers 2230-Answering reviewers.pdf
Copyright License Agreement 2230-Copyright assignment.pdf
Peer-review Report 2230-Peer review(s).pdf
Scientific Editor Work List 2230-Scientific editor work list.doc